Please login to the form below

Not currently logged in
Email:
Password:

Genentech

This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.

Morning brief: Takeda closes in on $64bn merger, GSK unveils team, and more

Morning brief: Takeda closes in on $64bn merger, GSK unveils team, and more

The ex-Genentech supremo will have also helped bring on board Kevin Sin, his former colleague at the Californian biotech who will now head up GSK’s worldwide business development for

Latest news

More from news
Approximately 4 fully matching, plus 256 partially matching documents found.

Latest Intelligence

  • Tackling the challenge of non-adherence Tackling the challenge of non-adherence

    A 2016 Best Practices LLC survey of leading drug manufacturers including Genentech Baxter BioScience, GlaxoSmithKline, Boehringer Ingelheim and Teva Pharmaceutical Industries revealed that 40% already have a dedicated big data group.

  • Deal Watch - May 2017 Deal Watch - May 2017

    It has signed deals with 10 companies in the last two years including Novartis, Genentech, Sanofi, Merck &Co and Lilly.

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    Positive results from a phase Ib dose-escalation study were presented and Roche’s Genentech unit is pushing on with its 60 mg/kg dose in a phase III trial of

  • Deal Watch September 2016 Deal Watch September 2016

    Genentech will provide an $80m upfront payment, up to $830m in milestone fees plus royalties on net sales. ... 1, 000+. Hanmi / Genentech. Licence. HM95573, a selective fibrosarcoma (RAF) kinase inhibitor targeting solid tumours.

  • A rising tide A rising tide

    Paying tribute to Cook, Ian Clark from Genentech told the HBA audience she was one of the rare people to truly understand both the science and business aspects of the industry. ... Jennifer first joined Genentech (now a Roche company) in 1987 and spent

More from intelligence
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest appointments

  • Juno Therapeutics names Cindy Elkins as CIO Juno Therapeutics names Cindy Elkins as CIO

    Juno Therapeutics names Cindy Elkins as CIO. She joins the biopharma from Genentech, where she was VP of IT. ... Elkins most recently served as vice president, IT for the Americas at Genentech, where she led its US commercial technology integration

  • Revolution Medicines appoints Dr Stephen Kelsey Revolution Medicines appoints Dr Stephen Kelsey

    Prior to his time at Onkaido Therapeutics, Kelsey has served in several senior positions at Medivation, Generon and Genentech, where he held the role of vice president, haematology and oncology.

  • BlackThorn Therapeutics appoints CEO BlackThorn Therapeutics appoints CEO

    Prior to this, Vontz was president and chief operating officer of Connetics Corporation, spent 12 years in a series of senior marketing and product development roles at Genentech, and worked in

  • MyoKardia appoints COO and medical affairs VP MyoKardia appoints COO and medical affairs VP

    Prior to this, Dr Lee was therapeutic area head for cardiovascular, metabolic, respiratory and infectious disease programmes at Genentech.

  • Dr Arndt Schottelius to lead Kymab’s R&D Dr Arndt Schottelius to lead Kymab’s R&D

    Previously, Dr Schottelius was medical director of immunology development at Genentech based in San Francisco, US, and held scientific and management positions in immunology research at Berlex Biosciences in California, US ... His strong management

More from appointments
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest from PMHub

  • Augmented Reality in patient communication – don’t miss out!

    Electronic Informed Consent Forms (e-ICFs) and Electronic Data Capture (EDC). In a recent well written article, Pierre Corin from Genentech discussed the drivers, advantages and possible challenges of using electronic ... References:. Pierre Corin,

  • It's time to change the conversation

    Changing the conversation with patients. One of the earliest adopters of technology and social media to change the conversation with patients, was Genentech. ... Starting from the position of caring about the patient, Genentech created the Herceptin

  • Augmented Reality in patient communication – don’t miss out!

    Electronic Informed Consent Forms (e-ICFs) and Electronic Data Capture (EDC). In a recent well written article, Pierre Corin from Genentech discussed the drivers, advantages and possible challenges of using electronic ... References:. Pierre Corin,

  • Top 7 Trends in Pharma Marketing for 2015

    Indeed, early Jan 2015 news that  Genentech, a member of the Roche Group, are collaborating with 23andMe to analyse genomic data for Parkinson’ s disease is proof of this.

  • Random42 Scientific Communication

    Genentech. Genzyme. Gilead. Grunenthal. GlaxoSmithKline. HCA Healthcare. Heron Therapeutics. Ignyta. Ironwood.

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics